Does chronic hemolysis increase the risk of black pigment gallstones?

Chronic hemolysis is a well-established driver for the development of black pigment gallstones, primarily due to the metabolic overload of the heme breakdown pathway.

Mechanistic evidence

The process begins with the accelerated destruction of red blood cells, which releases massive amounts of hemoglobin.

• Heme Catabolism: Free heme is first oxidized by Heme Oxygenase-1 (HO-1) to biliverdin, which is then reduced to unconjugated bilirubin (UCB). In chronic hemolytic states like hereditary spherocytosis, this overproduction often exceeds the liver's conjugation capacity, leading to systemic unconjugated hyperbilirubinemia.
• Hyperbilirubinbilia: To manage this load, the liver increases the secretion of bilirubin glucuronides (conjugated bilirubin) into the bile.
• Precipitation in Bile: Within the gallbladder, these bilirubin conjugates can be hydrolyzed by $\beta$-glucuronidase back into unconjugated bilirubin. Because UCB is highly insoluble in the aqueous environment of bile, it reacts with calcium ions to form calcium bilirubinate precipitates.
• Stone Polymerization: These precipitates serve as the "seeds" for stone formation. They aggregate on a mucin matrix and undergo oxidative polymerization, resulting in the hard, brittle, and typically sterile structures known as black pigment stones.

Clinical and effectiveness evidence

The risk of gallstones is significantly elevated in patients with chronic hemolytic disorders compared to the general population.

• Hereditary Spherocytosis (HS): In adults with HS, the prevalence of gallstones is reported between 43% and 63%. The magnitude of risk is closely tied to the rate of hemolysis and genetic modifiers, such as co-inherited Gilbert syndrome (UGT1A1 promoter mutations), which further impairs bilirubin conjugation and increases stone risk.
• Disease Severity: Clinical data show that while typical adult bilirubin levels in HS range from 1.5–4 mg/dL, severe cases (especially in neonates) can exceed 25 mg/dL.
• Surgical Impact: Splenectomy, by reducing the rate of extravascular hemolysis, has been shown to significantly lower indirect bilirubin levels and mitigate the ongoing risk of stone formation.

Practical considerations

• Diagnosis: Black pigment stones are distinct from the more common cholesterol stones; they are smaller, more numerous, and lack the high cholesterol content found in metabolic gallstone disease.
• Monitoring: In patients with known hemolytic anemia, regular ultrasound monitoring for cholelithiasis is standard, as these patients are at high risk for biliary complications, including cholecystitis and choledocholithiasis.
• Genetic Factors: The presence of disproportionately high unconjugated bilirubin levels in a hemolytic patient should prompt consideration of a dual diagnosis, such as HS combined with Gilbert syndrome, which dramatically increases the lithogenic (stone-forming) potential of the bile.

Bottom line

Chronic hemolysis directly raises the systemic unconjugated bilirubin load, which leads to "hyperbilirubinbilia." The subsequent hydrolysis of these conjugates in the gallbladder results in the precipitation of calcium bilirubinate and the formation of black pigment gallstones. This risk is particularly high in hereditary spherocytosis, where nearly half of affected adults may develop stones.